Galazka A - Search Results

1

Pharmacokinetics and pharmacodynamics of recombinant human interferon-beta in healthy male volunteers.

Salmon P, Le Cotonnec JY, Galazka A, Abdul-Ahad A, Darragh A. Salmon P, et al. Among authors: galazka a. J Interferon Cytokine Res. 1996 Oct;16(10):759-64. doi: 10.1089/jir.1996.16.759. J Interferon Cytokine Res. 1996. PMID: 8910759 Clinical Trial.

2

Randomised double-blind trial of recombinant interferon-beta for condyloma acuminatum.

Monsonego J, Cessot G, Ince SE, Galazka AR, Abdul-Ahad AK. Monsonego J, et al. Among authors: galazka ar. Genitourin Med. 1996 Apr;72(2):111-4. doi: 10.1136/sti.72.2.111. Genitourin Med. 1996. PMID: 8698357 Free PMC article. Clinical Trial.

3

Incidence of antibodies to interferon-beta in patients treated with recombinant human interferon-beta 1a from mammalian cells.

Abdul-Ahad AK, Galazka AR, Revel M, Biffoni M, Borden EC. Abdul-Ahad AK, et al. Among authors: galazka ar. Cytokines Cell Mol Ther. 1997 Mar;3(1):27-32. Cytokines Cell Mol Ther. 1997. PMID: 9287241 Clinical Trial.

4

Recombinant human interferon-beta in the treatment of condylomata acuminata.

Dinsmore W, Jordan J, O'Mahony C, Harris JR, McMillan A, Radcliffe KW, Engrand P, Jackson BW, Galazka AR, Abdul-Ahad AK, Illingworth JM. Dinsmore W, et al. Among authors: galazka ar. Int J STD AIDS. 1997 Oct;8(10):622-8. doi: 10.1258/0956462971918887. Int J STD AIDS. 1997. PMID: 9310221 Clinical Trial.

5

Treatment of multiple sclerosis with interferon beta-1 b.

Abdul-Ahad A, Shah S, Galazka A. Abdul-Ahad A, et al. Among authors: galazka a. Neurology. 1997 Aug;49(2):641-2. doi: 10.1212/wnl.49.2.641. Neurology. 1997. PMID: 9270626 No abstract available.

6

Interferon gamma in rheumatoid arthritis--a double blind study comparing human recombinant interferon gamma with placebo.

Veys EM, Mielants H, Verbruggen G, Grosclaude JP, Meyer W, Galazka A, Schindler J. Veys EM, et al. Among authors: galazka a. J Rheumatol. 1988 Apr;15(4):570-4. J Rheumatol. 1988. PMID: 3135392 Clinical Trial.

7

Interferon for treatment.

Galazka A, Scott E. Galazka A, et al. BMJ. 1988 Aug 20-27;297(6647):558-9. doi: 10.1136/bmj.297.6647.558-b. BMJ. 1988. PMID: 3139203 Free PMC article. Clinical Trial. No abstract available.

8

Clinical assessment of human gonadotrophins produced by recombinant DNA technology.

Loumaye E, Martineau I, Piazzi A, O'Dea L, Ince S, Howles C, Decosterd G, Van Loon K, Galazka A. Loumaye E, et al. Among authors: galazka a. Hum Reprod. 1996 Sep;11 Suppl 1:95-107; discussion 117-9. doi: 10.1093/humrep/11.suppl_5.95. Hum Reprod. 1996. PMID: 8968783 Review. No abstract available.

9

Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group.

Thorner M, Rochiccioli P, Colle M, Lanes R, Grunt J, Galazka A, Landy H, Eengrand P, Shah S. Thorner M, et al. Among authors: galazka a. J Clin Endocrinol Metab. 1996 Mar;81(3):1189-96. doi: 10.1210/jcem.81.3.8772599. J Clin Endocrinol Metab. 1996. PMID: 8772599 Clinical Trial.

10

Interferon beta treatment for multiple sclerosis.

Galazka A. Galazka A. Lancet. 1999 Feb 6;353(9151):495; author reply 497-8. doi: 10.1016/S0140-6736(05)75164-3. Lancet. 1999. PMID: 9989740 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

245 results

Search Page